DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 140 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q4 2023. The put-call ratio across all filers is 1.81 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $98,000 | +60.7% | 7,115 | +92.0% | 0.00% | – |
| Q1 2024 | $61,000 | -80.3% | 3,706 | -82.5% | 0.00% | – |
| Q4 2023 | $310,000 | +160.5% | 21,220 | +118.3% | 0.00% | – |
| Q3 2023 | $119,000 | +101.7% | 9,721 | +99.2% | 0.00% | – |
| Q2 2023 | $59,000 | +59.5% | 4,881 | +74.1% | 0.00% | – |
| Q1 2023 | $37,000 | -60.2% | 2,804 | -35.4% | 0.00% | – |
| Q4 2022 | $93,000 | +210.0% | 4,339 | +187.9% | 0.00% | – |
| Q3 2022 | $30,000 | +36.4% | 1,507 | +18.1% | 0.00% | – |
| Q2 2022 | $22,000 | -12.0% | 1,276 | -49.8% | 0.00% | – |
| Q1 2022 | $25,000 | -54.5% | 2,542 | -23.1% | 0.00% | – |
| Q4 2021 | $55,000 | +66.7% | 3,305 | +140.2% | 0.00% | – |
| Q3 2021 | $33,000 | – | 1,376 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,965,588 | $113,066,000 | 1.82% |
| Boxer Capital, LLC | 1,189,943 | $27,095,000 | 0.96% |
| BVF INC/IL | 918,975 | $20,925,000 | 0.78% |
| Samsara BioCapital, LLC | 202,500 | $4,611,000 | 0.57% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 818,980 | $18,648,000 | 0.33% |
| Perceptive Advisors | 1,512,094 | $34,430,000 | 0.22% |
| Rock Springs Capital Management LP | 373,739 | $8,510,000 | 0.17% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 434,423 | $9,892,000 | 0.13% |
| HealthCor Management, L.P. | 103,717 | $2,362,000 | 0.09% |
| VIKING GLOBAL INVESTORS LP | 1,341,396 | $30,544,000 | 0.09% |